Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

Results 61 - 61 of 61 : « Previous 1 2 3 4

Recs

0
Member Avatar RBBioContest06 (54.27) Submitted: 5/31/2006 10:29:36 PM : Outperform Start Price: $14.82 ALNY Score: -40.65

Picked by mebrownj

Report this Post Reply | Reply | Permalink
Results 61 - 61 of 61 : « Previous 1 2 3 4

Featured Broker Partners


Advertisement